Our Pricing

Acid Reflux Treatment Options & Alternatives

Published on: June 03, 2026

Searching for acid reflux treatment alternatives UK that address the root cause? At Cured Pharmacy, our UK-registered clinical team provides evidence-based guidance on managing gastro-oesophageal reflux disease (GORD), including prescription weight loss treatments that may significantly reduce reflux symptoms. Excess weight is one of the strongest modifiable risk factors for acid reflux, and targeted weight reduction can offer substantial relief alongside or instead of long-term acid suppression therapy.

How Weight Loss Reduces Acid Reflux Symptoms

Excess body weight, particularly abdominal adiposity, increases intra-abdominal pressure and mechanical stress on the lower oesophageal sphincter — the muscular valve that prevents stomach acid from flowing backward into the oesophagus [1]. Clinical studies demonstrate that even modest weight reduction of 5-10% can significantly improve GORD symptoms and reduce the need for daily proton pump inhibitors (PPIs).

A systematic review published in the American Journal of Gastroenterology found that patients who achieved weight loss through medical intervention experienced a 40% reduction in reflux episodes and improved oesophageal acid clearance [1]. For individuals with a BMI over 30, addressing weight becomes a cornerstone of comprehensive reflux management rather than simply masking symptoms with acid suppressants.

GLP-1 Receptor Agonists: Dual Benefits for GORD and Weight

GLP-1 receptor agonists such as semaglutide and liraglutide were initially developed for type 2 diabetes but are now licensed in the UK for weight management. These medications work by mimicking the natural hormone GLP-1, which regulates appetite, slows gastric emptying, and promotes satiety [2]. The resulting weight loss often translates to measurable improvements in reflux symptoms.

In the STEP trials evaluating semaglutide (Wegovy), participants achieved an average weight reduction of 15-17% over 68 weeks, with many reporting resolution or significant improvement in GORD symptoms as a secondary benefit [2]. Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, demonstrated even greater efficacy in the SURPASS trials, with average weight loss exceeding 20% at the highest dose [3].

Which GLP-1 Treatment Is Right for Your Reflux?

Your UK prescriber will assess your medical history, current medications, BMI, and reflux severity to recommend the most appropriate option. Saxenda requires daily injections and may suit patients preferring gradual titration, whilst Wegovy and Mounjaro offer once-weekly convenience with more pronounced weight loss outcomes. All prescription treatments available through Cured Pharmacy require a clinical assessment by a UK-registered prescriber to ensure safety and suitability.

Orlistat: Lipase Inhibitor for Gradual Weight Reduction

Orlistat works through a different mechanism than GLP-1 agonists — it inhibits pancreatic and gastric lipases, reducing dietary fat absorption by approximately 30% [4]. This leads to gradual, sustainable weight loss when combined with a reduced-calorie diet. Clinical trials show average weight loss of 5-10% over 12 months, which can be sufficient to reduce reflux frequency in overweight patients.

Available as prescription-strength Xenical (120mg) or lower-dose Alli and Orlos (60mg), orlistat may be appropriate for patients who prefer an oral medication or have contraindications to injectable treatments. Superintendent pharmacist Tarun Kumar notes that orlistat requires commitment to dietary modification, as high-fat meals can cause gastrointestinal side effects that discourage adherence.

Orlistat Formulations Compared

Xenical contains 120mg orlistat per capsule and is prescription-only, whilst Alli and Orlos contain 60mg and are available with pharmacist supervision. The higher-strength formulation blocks more dietary fat but requires stricter dietary compliance. Your prescriber will recommend the appropriate strength based on your weight loss goals, dietary habits, and reflux severity.

Acid Reflux Treatment Alternatives UK: Beyond Weight Loss

Whilst weight reduction remains the most effective long-term strategy for many GORD patients, other evidence-based alternatives include positional therapy (elevating the head of the bed by 15-20cm), dietary modification (avoiding trigger foods such as caffeine, alcohol, and high-fat meals), and smoking cessation [5]. These lifestyle interventions work synergistically with weight loss to reduce reflux episodes.

For patients requiring pharmacological intervention, PPIs such as omeprazole remain the gold standard for acid suppression, but long-term use carries risks including nutrient malabsorption, increased fracture risk, and potential rebound hypersecretion upon discontinuation [5]. Combining weight loss with intermittent or reduced-dose PPI therapy may allow many patients to step down from daily acid suppression whilst maintaining symptom control.

Clinical Assessment Process at Cured Pharmacy

All prescription weight loss treatments available through Cured Pharmacy require a free online clinical assessment completed in under three minutes. Our UK-registered prescribers review your medical history, current medications, BMI, and reflux symptoms to determine the safest and most effective treatment option. You'll receive transparent upfront pricing before your consultation — no hidden fees or surprise charges.

If a prescription is issued, your medication is dispensed by our GPhC-registered pharmacy (registration number 9012511) and delivered in 100% discreet packaging. Our clinical team remains available for ongoing support throughout your treatment journey, with regular follow-up assessments to monitor progress and adjust therapy as needed.

What to Expect During Your Consultation

Your UK prescriber will ask about the frequency and severity of your reflux symptoms, previous treatments tried (including PPIs and H2 blockers), current weight and height, any comorbidities such as hiatus hernia or Barrett's oesophagus, and medications that may interact with weight loss treatments. This comprehensive assessment ensures you receive personalised care that addresses both your weight and reflux concerns safely.

Combining Weight Loss with Reflux Medications Safely

Many patients beginning weight loss therapy are already taking daily PPIs or H2 receptor antagonists for reflux control. GLP-1 receptor agonists and orlistat can generally be used alongside these medications, though your prescriber may recommend gradual dose reduction of acid suppressants as weight loss progresses and symptoms improve [6].

It's essential to inform your prescriber of all current medications during your clinical assessment, as some drug interactions require dose adjustments or additional monitoring. For example, GLP-1 agonists slow gastric emptying, which may affect the absorption timing of oral medications including thyroid hormones and oral contraceptives [6]. Your Cured Pharmacy clinical team will provide specific guidance tailored to your medication regimen.

Scientific References

1. Singh, M., Lee, J., Gupta, N., Gaddam, S., Smith, B. K., Wani, S. B., Sullivan, D. K., Rastogi, A., & Bansal, A. (2013). Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity, 21(2), 284–290. https://doi.org/10.1002/oby.20279 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
4. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
5. Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology, 108(3), 308–328. https://doi.org/10.1038/ajg.2012.444 [accessed 13 August 2026]
6. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102 [accessed 13 August 2026]
7. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.